High-Dose Facilitated Subcutaneous Immunoglobulin in a Patient with Refractory Polymyositis and Severe Interstitial Lung Disease.
High-Dose Facilitated Subcutaneous Immunoglobulin in a Patient with Refractory Polymyositis and Severe Interstitial Lung Disease.
Isr Med Assoc J. 2019 Jul;21(7):494-496
Authors: Giovanna Danieli M, Menghini D, Mezzanotte C, Gelardi C, Pedini V, Monteforte F
PMID: 31507128 [PubMed - in process]
Source: The Israel Medical Association Journal - Category: General Medicine Tags: Isr Med Assoc J Source Type: research
More News: General Medicine | Interstitial Lung Disease | Israel Health | Men | Middle East Health | Polymyositis